8-KLeadership ChangesExhibits & Filings

WELLTOWER INC. 8-K Report, Executive Changes (Jan 25, 2008)

Filed January 25, 2008For Securities:WELL

Summary

Health Care REIT, Inc. (WELL) announced a change in its board of directors via an 8-K filing on January 25, 2008. The company expanded its board from ten to eleven directors and appointed Jeffrey R. Otten as a Class II director, with his term expiring in 2009. Mr. Otten will also serve on the Investment and Planning Committees. This appointment is accompanied by a standard indemnification agreement, designed to protect Mr. Otten against certain liabilities arising from his service to the company. While this filing does not disclose significant financial performance or strategic shifts, it indicates a board expansion and the addition of a new director with committee assignments.

Key Highlights

  • 1Appointment of Jeffrey R. Otten as a new Class II director, expanding the board to eleven members.
  • 2Mr. Otten's term as director is set to expire in 2009.
  • 3Mr. Otten will serve on the Investment and Planning Committees.
  • 4The company entered into a standard indemnification agreement with Mr. Otten.
  • 5The indemnification agreement covers certain expenses and liabilities related to his directorship.
  • 6A press release dated January 23, 2008, announcing the appointment is attached as an exhibit.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce the appointment of a new director, Jeffrey R. Otten, to the Board of Directors of Health Care REIT, Inc. and the expansion of the board size.

Mr. Otten has been appointed as a Class II director and will serve on the Investment and Planning Committees of the Board of Directors.

The indemnification agreement is a standard contract that generally protects Mr. Otten from personal financial loss by agreeing to cover certain expenses, judgments, fines, penalties, and settlement amounts arising from his service as a director, provided certain conditions are met.

No, this particular 8-K filing does not contain any financial performance updates. It focuses solely on corporate governance changes related to the board of directors.